Alleviation of experimental allergic encephalomyelitis in C57BL/6 mice by soy daidzein.

In conclusion, daidzein reduced the extent of demyelination and disease severity. Chronic oral therapy with low dose of daidzein did not prevent experimental autoimmune encephalomyelitis. However, high doses of daidzein could prohibit disease exacerbation. 
PMID: 24659161 [PubMed - in process]

Source: Iranian Journal of Allergy, Asthma and Immunology - March 29, 2014 Category: Allergy & Immunology Authors: Razeghi Jahromi S, Arrefhosseini SR, Ghaemi A, Alizadeh A, Moradi Tabriz H, Togha M Tags: Iran J Allergy Asthma Immunol Source Type: research